ADVANCED USE OF COENZYME Q10 IN PATIENTS WITH CARDIOVASCULAR DISEASES

This report examines interest in compounds that normally prevent the toxic effects of ROS -antioxidants, namely reduced ubiquinone, which is only lipid soluble antioxidant synthesized in cells of animals and humans, and continuously recovered from oxidized form by enzyme systems of the body, to possibilities of the use of coenzyme Q10 in cardiovascular diseases, has a beneficial therapeutic effect on the body, resulting in improvement of the cardiovascular, immune system, significant improvement in rehabilitation period, a significant increase in body energy, the use of coenzyme Q10, including in pediatric cardiology and study its effectiveness in primary and secondary mitochondrial defects as a means of adjuvant therapy of diseases and pathological conditions, as vegetative dystonia, diabetic kardioneyropatiya, myocardial dystrophy, hypertension, metabolic syndrome, cardiomyopathy posthypoxic newborn, chronic pulmonary heart, hyperlipidemia, the recovery period after cardiac correction of congenital heart disease, minimally invasive correction of arrhythmias and pacemaker implantation, etc. reperfusion syndrome, ischemia, hypertension, heart disease, aging, childhood.

Коэнзим Q10, убихинон, антиоксидант, атеросклероз, инфаркт миокарда, реперфузионный синдром, ишемия, артериальная гипертония, сердечная недостаточность, старение, детский возраст, Coenzyme Q10, ubiquinone, antioxidant, atherosclerosis, myocardial infarction

1. Bagchi D., Sen C.K., Ray S.D., Das D.K., Bagchi M., Preuss H.G., Vinson J.A. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003; 523524: 87-97

2. Cheraskin E. Antioxidants in health and disease. J Am Optom Assoc 1996 ; 67(1): 50-55

3. Капелько В.И. «Активные формы кислорода, антиоксиданты и профилактика заболеваний сердца».

4. Капелько В.И., Рууге Э.К. Убихинон: роль в метаболизме клеток и применение в кардиологии. Кардиология 2002.

5. Hughes K., Lee B.L., Feng X., Ong C.N. «Coenzyme Q10 and differences in coronary heart disease risk in Asian Indians and Chinese» Free. Radic. Biol. Med., 2002, 15,32(2), 132-138.

6. Thomas S.R., Jifi N., Stocker R. «Cosupplementation with coenzyme Q10 prevents the prooxidant effects of tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation» Arteriosclerosis, Thrombosis and Vascular Biology, 1996, 16, 687-696.

7. Aejmelaeus R., Metsa-Ketela T. et al. «Ubiquinol-10 and total peroxil radical trapping capacity of LDL lipoproteins during aging: the effects of Q-10 supplementation» Mol. Aspects. Med., 1997, 18, 113-120.

8. Cheraskin E. Antioxidants in health and disease. J Am Optom Assoc 1996 ; 67(1): 55-57.

9. Лакомкин В.Л., Коркина О.В. и соавт. «Защитное действие убихинона (коэнзима Q10) при ишемии и реперфузии сердца» Кардиология, 2002, 12, 51-55.2.

10. Singh R.B., Shinde S.N., Chopra R.K., et al. «Effect of coenzyme Q10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits» Atherosclerosis, 2000, 148(2), 275-282.

11. Ланкин В.З., Тихазе А.К., Беленков Ю.Н. «Антиоксиданты в комплексной терапии атеросклероза: pro et contra» Кардиология, 2004, 2, 72-81.

12. Singh R.B., Niaz M.A. «Serum concentration of lipoprotein(a) decreases on treatment with hydrsoluble coenzyme Q10 in patients with coronary artery disease: discovery of a new role» Int.J.Cardiol., 1999,68(1), 23-29

13. Crestanello J.A., Doliba N.M. et al. «Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion» J.Surg. Res., 2002, 102(2), 221-228.

14. Murad N., Takiuchi K. et al. «Coenzyme Q10 exogenous administration attenuates cold stress cardiac injury» Jpn.Heart. J., 2001, 42(3), 327-338

15. Аронов Д.М. «Применение коэнзима Q10 в кардиологической практике» Рус. Мед. Журн. 2007, № 20, с. 1485.

16. Гороховская Г.Н., Е.В. Чернецова, М.М. Петина. «Перспективы применения коэнзима Q10 в профилактике и лечении сердечно-сосудиcтых заболеваний» Атмосфера 2008, № 4, 8-14.

17. Mortinsen S.A. «Overview of coenzyme Q10 as adjunctive therapy in chronic heart failure. Rationale, design and end-points of «Q-symbio»-a multinational trial» Biofactors, 2003, 18, 79-89.

18. Rosenfeldt F., Hilton D., Pepe S., Krum H. «Systematic review of effect of coenzyme Q10 in phtysical exercise, hypertension and heart failure» Biofactors, 2003, 18(1-4), 91-100.

19. Morisco C., Trimarco B., Condorelli M. "Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study" Clin.Investig., 1993, 71(8), 134-136. 24.

20. Langsjoen P.H. and Folkers K. Long-term efficacy and safety of coenzyme Q10therapy for idiopathic dilated cardiomyopathy // American Journal of Cardiology. - 1990. - V. 7. - № 65. - р. 521-523.

21. Pignatti C., Cocchi M., Weiss H. «Coenzyme Q10 levels in rat heart of different age» Biochem.Exp. Biol., 1980, 16(1), 39-42.

22. Lenaz G., D'Aurelio M., Merlo Pich M. et al. «Mitochondrial bioenergetics in aging» Biochim. Biophys. Acta, 2000, 1459(2-3), 3997-404.

23. Senoo-Matsuda, N.; Miyake, K.; Yasuda, K.; Ishii, T.; Hartman, P.S.; Furukawa, S. (2004). «Coenzyme Q10 can prolong C. elegans lifespan by lowering oxidative stress».

24. Аронов Д.М. «Применение коэнзима Q10 в кардиологической практике» Рус.мед.журнал 2006, № 4, с. 223.